Global Vascular Closure Systems Market Size By Type (Vascular Closure Devices, Sealant and Suture), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Vascular Closure Systems Market was valued at USD 1.2 billion in 2023 and is projected to reach USD 2.1 billion by 2031, growing at a CAGR of 7.3% during the forecast period (2023–2031). The market is driven by the increasing volume of cardiovascular procedures, growing preference for minimally invasive surgeries, and advancements in closure device technologies. Vascular closure systems (VCS) are essential in achieving rapid hemostasis post-procedures like angiography and angioplasty, leading to reduced hospital stays and improved patient outcomes. Rising cases of lifestyle diseases and the expanding geriatric population are further contributing to the increasing demand for these devices globally.

Drivers:

1. Rising Number of Cardiovascular Interventions:

The surge in angiographic and interventional cardiology procedures worldwide, driven by increasing cases of coronary artery diseases and peripheral artery diseases, fuels the demand for efficient vascular closure techniques.

2. Shift Towards Minimally Invasive Surgeries:

A growing inclination toward minimally invasive procedures, which promote faster recovery and reduced complications, is enhancing the adoption of vascular closure systems.

3. Technological Advancements in Closure Devices:

Innovations such as bioresorbable plugs, suture-based systems, and active approximators have significantly improved patient comfort and clinical outcomes, bolstering market growth.

Restraints:

1. Risk of Complications:

Despite improved designs, some closure systems still present risks of infection, bleeding, and arterial occlusion, limiting their adoption in certain patient populations.

2. High Cost of Advanced Systems:

The relatively high cost of technologically advanced closure devices can be a barrier, particularly in low- and middle-income regions.

Opportunity:

1. Expanding Healthcare Infrastructure in Emerging Markets:

Rapid healthcare development in Asia-Pacific, Latin America, and parts of the Middle East offers untapped potential for market expansion, supported by increasing access to cardiovascular care.

2. Growing Use in Outpatient Settings:

The trend toward same-day discharge after angiographic procedures increases the demand for reliable closure devices that allow early ambulation and improved patient throughput.

Market by System Type Insights:

Based on system type, the Passive Approximators segment held the largest market share in 2023. These systems are widely adopted due to their ease of use and cost-effectiveness. However, the Active Approximators segment is expected to witness the fastest growth owing to their superior hemostatic performance and reduced time to ambulation.

Market by End-use Insights:

In terms of end-use, Hospitals dominated the market in 2023, accounting for more than 50% of global revenue. Hospitals remain the primary settings for angiographic and interventional procedures. Meanwhile, Ambulatory Surgical Centers (ASCs) are anticipated to grow rapidly due to their cost-efficiency and the shift toward outpatient procedures.

Market by Regional Insights:

North America led the global vascular closure systems market in 2023 due to high healthcare spending, robust reimbursement structures, and early adoption of advanced technologies. However, Asia-Pacific is projected to register the fastest CAGR over the forecast period, driven by rising healthcare awareness, improving infrastructure, and increasing procedural volumes in countries like China and India.

Competitive Scenario:

Leading companies in the global vascular closure systems market include Abbott Laboratories, Terumo Corporation, Cardinal Health, Teleflex Incorporated, and Morris Innovative, Inc. These players are investing in product innovations, expanding their geographic reach, and pursuing strategic mergers and acquisitions.

Recent Developments:

In 2024, Abbott received FDA approval for its next-gen collagen-based closure system with faster time to hemostasis.

Teleflex launched its suture-mediated closure device in select European markets in 2023.

Terumo Corporation partnered with leading hospitals in Asia-Pacific to promote training on its vascular closure portfolio.

Scope of Work – Global Vascular Closure Systems Market

Report Metric Details

Market Size (2023) USD 1.2 billion

Projected Market Size (2031) USD 2.1 billion

CAGR (2023–2031) 7.3%

Key Segments by System Type Passive Approximators, Active Approximators

Key Segments by End-use Hospitals, Ambulatory Surgical Centers (ASCs)

Leading Region North America

Key Players Abbott Laboratories, Terumo, Teleflex, Cardinal Health, Morris Innovative Inc.

Market Drivers Increase in cardiovascular procedures, minimally invasive trends, technology advancement

Market Opportunities Expansion in emerging markets, outpatient procedure growth

Key Market Developments:

2023: Abbott launched a collagen plug system with reduced closure time.

2024: Teleflex introduced an enhanced suture-based device with improved ergonomic design.

2025: Terumo expanded its vascular closure training program to South America and Southeast Asia.

FAQs:

1) What is the current market size of the Global Vascular Closure Systems Market?

The market was valued at USD 1.2 billion in 2023.

2) What is the major growth driver of the Global Vascular Closure Systems Market?

The major growth driver is the increasing number of cardiovascular interventions and minimally invasive surgeries.

3) Which is the largest region during the forecast period in the Global Vascular Closure Systems Market?

North America holds the largest market share due to early adoption a